Switzerland's Idorsia has submitted a new drug application to the FDA for aprocitentan as a treatment for people whose blood pressure remains stubbornly high despite treatment and who are a
People whose blood pressure remains stubbornly high despite current drug treatment and are at increased risk of complications such as kidney disease and stroke could have another treatment
George Medicines has partnered with Medisante to provide technology for a study of an experimental triple therapy for hypertension that will allow most subjects to provide data from their o
